282 related articles for article (PubMed ID: 22111975)
1. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
Yehia SA; Elshafeey AH; Elsayed I
Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
[TBL] [Abstract][Full Text] [Related]
2. Optimization of budesonide compression-coated tablets for colonic delivery.
Yehia SA; Elshafeey AH; Sayed I; Shehata AH
AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
[TBL] [Abstract][Full Text] [Related]
3. Highly specific colon-targeted transformable capsules containing indomethacin immediate-release pellets for colon cancers therapy.
Yang C; Zhang Y; Cai P; Yuan S; Ma Q; Song Y; Wei H; Wu Z; Wu Z; Qi X
J Drug Target; 2020 Jan; 28(1):102-110. PubMed ID: 31100991
[TBL] [Abstract][Full Text] [Related]
4. Investigation and comparison of colon specificity of novel polymer khaya gum with guar gum.
Prabhu P; Ahamed N; Matapady HN; Ahmed MG; Narayanacharyulu R; Satyanarayana D; Subrahmanayam E
Pak J Pharm Sci; 2010 Jul; 23(3):259-65. PubMed ID: 20566437
[TBL] [Abstract][Full Text] [Related]
5. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
[TBL] [Abstract][Full Text] [Related]
7. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
Gohel MC; Sumitra G M
J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of pectin-based colon-specific pulsatile capsule in vitro and in vivo.
Liu J; Zhang L; Jia Y; Hu W; Zhang J; Jiang H
Arch Pharm Res; 2012 Nov; 35(11):1927-34. PubMed ID: 23212634
[TBL] [Abstract][Full Text] [Related]
9. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
10. Guar gum as potential film coating material for colon-specific delivery of fluorouracil.
Ji CM; Xu HN; Wu W
J Biomater Appl; 2009 Jan; 23(4):311-29. PubMed ID: 18667456
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers.
Hodges LA; Connolly SM; Band J; O'Mahony B; Ugurlu T; Turkoglu M; Wilson CG; Stevens HN
Int J Pharm; 2009 Mar; 370(1-2):144-50. PubMed ID: 19114096
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and In-vivo Pharmacokinetic Evaluation of Guar Gum-Eudragit® S100 Based Colon-targeted Spheroids of Sulfasalazine Co-administered with Probiotics.
Sharma A; Kumar B; Singh SK; Gulati M; Vaidya Y; ; Rathee H; Ghai D; Malik AH; Yadav AK; Maharshi P; Bawa P; Rajesh SY; Sharma P; Pandey NK; Mohanta S
Curr Drug Deliv; 2018; 15(3):367-387. PubMed ID: 29219056
[TBL] [Abstract][Full Text] [Related]
13. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
Mughal MA; Iqbal Z; Neau SH
AAPS PharmSciTech; 2011 Mar; 12(1):77-87. PubMed ID: 21174179
[TBL] [Abstract][Full Text] [Related]
14. Budesonide-loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro/in vivo evaluation.
Liu Y; Zhou H
Int J Mol Sci; 2015 Jan; 16(2):2693-704. PubMed ID: 25629228
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
16. Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.
Marvola T; Marvola J; Kanerva H; Ahonen A; Lindevall K; Marvola M
Int J Pharm; 2008 Feb; 349(1-2):24-9. PubMed ID: 17869037
[TBL] [Abstract][Full Text] [Related]
17. Colon specific delivery of budesonide based on triple coated pellets: in vitro/in vivo evaluation.
Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Rahmani N; Dorkoosh F; Mahzouni P
Acta Pharm; 2012 Nov; 62(3):341-56. PubMed ID: 23470347
[TBL] [Abstract][Full Text] [Related]
18. Formulation and development of gastroretentive drug delivery system for ofloxacin.
Ali J; Hasan S; Ali M
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Albizia procera gum as compression coating material for colonic delivery of budesonide.
Pachuau L; Mazumder B
Int J Biol Macromol; 2013 Oct; 61():333-9. PubMed ID: 23916644
[TBL] [Abstract][Full Text] [Related]
20. Colon targeted curcumin delivery using guar gum.
Elias EJ; Anil S; Ahmad S; Daud A
Nat Prod Commun; 2010 Jun; 5(6):915-8. PubMed ID: 20614824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
